Mediyork Pharma Profile
Key Indicators
- Authorised Capital ₹ 1.00 M
as on 20-12-2024
- Paid Up Capital ₹ 1.00 M
as on 20-12-2024
- Company Age 5 Year, 6 Months
- Last Filing with ROC 31 Mar 2022
- Open Charges ₹ 4.90 M
as on 20-12-2024
About Mediyork Pharma
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2022. It's a company limited by shares with an authorized capital of Rs 1.00 M and a paid-up capital of Rs 1.00 M.
The company currently has active open charges totaling ₹4.90 M.
Aekansh Verma and Ridham Verma serve as directors at the Company.
- CIN/LLPIN
U24299CH2019PTC042616
- Company No.
042616
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
11 Jul 2019
- Date of AGM
30 Sep 2022
- Date of Balance Sheet
31 Mar 2022
- Listing Status
Unlisted
- ROC Code
Roc Chandigarh
Industry
Company Details
- Location
Chandigarh, India
- Telephone
- Email Address
- Website
- Social Media
What products or services does Mediyork Pharma Private Limited offer?
Mediyork Pharma Private Limited offers a wide range of products and services, including TB, Tumor & Cancer Drugs, Anti Cancer Medicines, Nutraceuticals & Dietary Supplements, Vitamin Tablets & Capsules, Mineral Supplement, Digestive System Drugs & Medicines, Anti Ulcer Drugs, Common Disease Medicines, Pharmaceutical Syrup, Pain Relief Drugs & Pharmaceuticals.
Who are the key members and board of directors at Mediyork Pharma?
Board Members(2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Aekansh Verma  | Director | 10-Dec-2020 | Current |
| Ridham Verma | Director | 22-Jul-2022 | Current |
Financial Performance of Mediyork Pharma.
Mediyork Pharma Private Limited, for the financial year ended 2020, experienced no change in revenue, with a 0% increase. The company also saw a no change in profitability, with a 0% increase in profit. The company's net worth witnessed no change by increase of 0%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue | |||||||
| Revenue from Operations | |||||||
| Total Assets | |||||||
| Profit or Loss | |||||||
| Net Worth | |||||||
| EBITDA |
What is the Ownership and Shareholding Structure of Mediyork Pharma?
In 2020, Mediyork Pharma had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
State Bank Of India Creation Date: 15 Dec 2020 | ₹4.90 M | Open |
How Many Employees Work at Mediyork Pharma?
Unlock and access historical data on people associated with Mediyork Pharma, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Mediyork Pharma, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Mediyork Pharma's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
